Listen: Is the Nobel committee evolving? Plus, preventing public health’s wiliest virus

Will we ever get an HIV vaccine? And is the oft-criticized institution that awards the Nobel Prize each year showing signs of evolution?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. It’s Nobel week on the podcast, and reporter Megan Molteni details the unique story of this year’s winners for medicine, Katalin Karikó and Drew Weissman. Then, our colleague Jason Mast joins us to explain the scientific and ethical quandaries facing the teams attempting to develop HIV vaccines. 

For more on what we cover, here’s the story on Karikó and Weissman’s partnership; Here’s more on the struggles Karikó faced while developing messenger RNA; Here are the details on the struggle for an HIV vaccine; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In